Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

0.4500 -0.0258 (-5.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Panama Grants 7 Medical Cannabis Licenses: Which Companies Got Them?
By Javier Hasse via El Planteo 
Via Benzinga
Topics Cannabis
Exposures Cannabis
5 Largest Canadian Cannabis Stocks Down 5%, On Average, This Week
The 5 largest stocks in the Canadian Cannabis LP Stocks Index were down 65.0%, on average, in 2023; 71% decline in 2022; and 61% in 2021. If the first two weeks of 2024 are any indication, 2024 may... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The 7 Best Meme Stocks to Buy in January 2024
These are the best meme stocks to buy as they represent companies with a positive business outlook and high social media interest. 
Via InvestorPlace
Why Tilray Brands Stock Crashed 10% on Tuesday
Can Tilray stock deliver on its promise of positive free cash flow in 2024? 
Via The Motley Fool
TLRY Stock Earnings: Tilray Brands Misses Revenue for Q2 2024
TLRY stock results show that Tilray Brands missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Tilray Brands Earnings Preview
Via Benzinga
Why Tilray Brands Stock Fell 16.7% This Week
The cannabis and alcoholic beverage leader delivered a solid quarter that was technically mixed relative to expectations. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's Going On With Tilray Brands Stock?
According to an SEC filing, Tilray entered into an assignment and assumption agreement with Double Diamond Holdings Ltd. (DDH) on Jan. 9. Tilray acquired a promissory note in the amount of... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
EQNX::TICKER_START (OTCQB:PBIO),(NASDAQ:CGC),(NASDAQ:TLRY),(NASDAQ:CRON),(OTCQX:CWBHF) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
From FN Media Group LLC
Via GlobeNewswire
7 Stocks Primed to Explode Your Net Worth by 2030
These are the high-growth stocks to buy as they represent high potential companies poised for healthy growth in cash flows. 
Via InvestorPlace
Cannabis Stock Movers For January 10, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 3 Best Cannabis Stocks to Buy in January 2024
With the 2024 U.S. presidential election just months away, some of the best cannabis stocks should benefit. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
420 with CNW — Five Predictions for the Marijuana Industry in 2024
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For January 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Brands (TLRY) Q2 2024 Earnings Call Transcript
TLRY earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
Tilray Brands Inc. (NASDAQ: TLRY) is One of Tuesday Morning’s Most Active Stocks
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Tilray's Diversified Growth Strategy Is Paying Off, Here's What's Behind 34% YoY Revenue Increase In Q2
Canadian cannabis company Tilray reported a 34% increase in revenue in its second quarter of fiscal 2024. The company reported revenue of $194 million, up from $145 million in the same period last... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For January 9, 2024
Companies Reporting Before The Bell • TD Synnex (NYSE:SNX) is likely to report quarterly earnings at $2.68 per share on revenue of $14.47 billion. 
Via Benzinga
Tilray Brands Delivers Record Q2 Fiscal 2024 Net Revenue
From Tilray Brands, Inc.
Via GlobeNewswire
Bullish Monday For Marijuana Stocks - Australis Capital, EVIO Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tilray’s Downfall: Why TLRY Stock Isn’t the High Investors Hoped For
Investors should run, not walk, from this cannabis producer, which seemingly has insurmountable challenges. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The 3 Hottest Cannabis Stocks to Watch in 2024
These are the hot cannabis stocks to buy as they represent companies positioned for survive and accelerated growth in U.S. and Europe 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent. 
Via InvestorPlace
Cathie Wood Is Buying Up Tesla (TSLA) Stock
Tesla is on the move Thursday after it was revealed that investor Cathie Wood bought 216,000 shares of TSLA stock for $25.09 million. 
Via InvestorPlace
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.